Measurement and evaluation of serum anti-p53 antibody levels in patients with lung cancer at its initial presentation: A prospective study

British Journal of Cancer

Volumn 78, Issue 5, 1998, Pages 667-672

  Segawa, Y ^a   Kageyama, M ^b   Suzuki, S ^b   Jinno, K ^a   Takigawa, N ^a   Fujimoto, N ^a   Hotta, K ^a   Eguchi, K ^a  

^a NATIONAL HOSPITAL ORGANIZATION SHIKOKU CANCER CENTER   (Japan)

^b LSI MEDIENCE CORPORATION   (Japan)

Author keywords

Enzyme linked immunosorbent assay; Lung cancer; Serum anti p53 antibody

Indexed keywords

ANTIBODY; PROTEIN P53;

ADULT; AGED; ANTIBODY BLOOD LEVEL; ARTICLE; CONTROLLED STUDY; ENZYME LINKED IMMUNOSORBENT ASSAY; FEMALE; HISTOPATHOLOGY; HUMAN; LARGE CELL CARCINOMA; LUNG ADENOCARCINOMA; LUNG CANCER; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; SMALL CELL CARCINOMA; SQUAMOUS CELL CARCINOMA;

EID: 0031927130     PISSN: 00070920     EISSN: None     Source Type: Journal    
DOI: 10.1038/bjc.1998.557     Document Type: Article

References (28)

1. Caron de Fromental C, May-Levin F, Mouriesse H, Lemerle J, Chandrasekaran K and May P (1987) Presence of circulating antibodies against cellular protein p53 in a nortable proportion of children with B-cell lymphoma. Int J Cancer 39: 185-189
2. Chang F, Syrjänen S and Syrjänen K (1995) Implications of the p53 tumour-suppressor gene in clinical oncology. J Clin Oncol 13: 1009-1022
3. Crawfort LV, Pim DC and Bulbrook RD (1982) Detection of antibodies against the cellular protein p53 in sera from patients with breast cancer. Int J Cancer 30: 403-408
4. Davidoff AM, Iglehart JD and Marks JR (1992) Immune response to p53 is dependent upon p53/HSP70 complexes in breast cancers. Proc Natl Acad Sci USA 89: 3439-3442
5. Green JA, Mudenda B, Jenkins J, Leinster SJ, Tarunina M, Green B and Robertson L (1994) Serum p53 autoantibodies: incidence in familial breast cancer. Eur J Cancer 30A: 580-584
6. Harris CC and Hollstein M (1993) Clinical implications of the p53 tumor-suppressor gene. N Engl J Med 329: 1318-1327
7. Hollstein M, Sidransky D, Vogelstein B and Hallis CC (1991) p53 mutations in human cancers. Science 253: 49-53
8. Johnson BE (1995) Biology of lung cancer. In Lung Cancer, Johnson BE and Johnson DH (eds), pp. 15-40. Wiley-Liss: New York
9. Klapdor R (1992) Arbeitsgruppe Qualitätskontrolle und Standardisierung von Tumormarkertests im Rahmen der Hamburger Symposien über Tumormarker (in German). Tumordigan u Ther 13: 19-22
10. Labrecque S, Naor N, Thomson D and Matlashewski G (1993) Analysis of the anti-p53 antibody response in cancer patients. Cancer Res 53: 3468-3471
11. Levine AJ, Momand J and Finlay CA (1991) The p53 tumour suppressor gene. Nature 351: 453-456
12. Lubin R, Schlichtholz B, Bengoufa D, Zalcman G, Trédaniel J, Hirsch A, Caron de Fromental C, Preudhomme C, Fenaux P, Fournier G, Mangin P, Laurent-Puig P, Pelletier G, Schlumberger M, Desgrandchamps F, Le Duc A, Peyrat JP, Janin N, Bressac B and Soussi T (1993) Analysis of p53 antibodies in patients with various cancers define B-cell epitopes of human p53: distribution of primary structure and exposure on protein surface. Cancer Res 53: 5872-5876
13. Lubin R, Zalcman G, Bouchet L, Trédaniel J, Legros Y, Cazals D, Hirsch A and Soussi T (1995) Serum p53 antibodies as early markers of lung cancer. Nature Med 1: 701-702
14. Metz CE (1991) CLABROC User's Guide: Apple Macintosh™ Version. The University of Chicago: Chicago
15. Mountain CF (1986) A new international staging system for lung cancer. Chest 89: 225S-233S
16. Mudenda B, Green JA, Green B, Jenkins JR, Robertson L, Tarunina M and Leinster SJ (1994) The relationship between serum p53 autoantibodies and characteristics of human breast cancer. Br J Cancer 69: 1115-1119
17. Muller M, Volkmann M, Zentgraf H and Galle PR (1994) Clinical implications of the p53 tumor-suppressor gene. N Engl J Med 330: 865
18. Peyrat J, Bonneterre J, Lubin R, Vanlemmens L, Fournier J and Soussi T (1995) Prognostic significance of circulating p53 antibodies in patients undergoing surgery for locoregional breast cancer. Lancet 345: 621-622
19. Schlichtholz B, Legros Y, Gillet D, Gaillard C, Marty M, Lane D, Calvo F and Soussi T (1992) The immune response to p53 in breast cancer patients is directed against immunodominant epitopes unrelated to the mutational hot spot. Cancer Res 52: 6380-6384
20. Schlichtholz B, Trédaniel J, Lubin R, Zalcman G, Hirsch A and Soussi T (1994) Analyses of p53 antibodies in sera of patients with lung carcinoma define immunodominant regions in the p53 protein. Br J Cancer 69: 809-816
21. Segawa Y, Takigawa N, Mandai K, Maeda Y, Takata I, Fujimoto N and Jinno K (1997a) Measurement of serum p53 protein in patients with small cell lung cancer and results of its clinicopathological evaluation. Lung Cancer 16: 229-238
22. Segawa Y, Takigawa N, Kataoka M, Takata I, Fujimoto N and Ueoka H (1997b) Risk factors for development of radiation pneumonitis following radiation therapy with or without chemotherapy for lung cancer. Int J Radiat Oncol Biol Phys 39: 91-98
23. Sundaresan V, Ganly P, Hasleton P, Rudd R, Sinha G, Bleehen NM and Rabbitts P (1992) p53 and chromosome 3 abnormalities, characteristic of malignant lung tumours, are detectable in preinvasive lesions of the bronchus. Oncogene 7: 1989-1997
24. Trivers GE, Cawley HL, De Benedetti VM, Hollstein M, Marion MJ, Bennett WP, Hoover ML, Prives CC, Tamburro CC and Harris CC (1995) Anti-p53 antibodies in sera of workers occupationally exposed to vinyl chloride. J Natl Cancer Inst 87: 1400-1407
25. Trivers GE, De Benedetti VM, Cawley HL, Caron G, Harrington AM, Bennett WP, Jett JR, Colby TV, Tazelaar H, Pairolero P, Miller RD and Harris CC (1996) Anti-p53 antibodies in sera from patients with chronic obstructive pulmonary disease can predate a diagnosis of cancer. Clin Cancer Res 2: 1767-1775
26. Winter SF, Minna JD, Johnson BE, Takahashi T, Gazdar AF and Carbone DP (1992) Development of antibodies against p53 in lung cancer patients appears to be dependent on the type of p53 mutation. Cancer Res 52: 4168-4174
27. Winter SF, Sekido Y, Minna JD, McIntire D, Johnson BE, Gazdar AF and Carbone DP (1993) Antibodies against autologous tumor cell proteins in patients with small-cell lung cancer: association with improved survival. J Natl Cancer Inst 85: 2012-2018
28. World Health Organization (1982) Histological typing of lung tumours, 2nd edn. Am J Clin Pathol 77: 123-136